THE ASSOCIATED PRESS
The U.S. Food and Drug Administration is allowing the problem-plagued factory of contract manufacturer Emergent BioSolutions to resume production of COVID-19 vaccine, the company said Thursday. The Baltimore factory was shut down by the FDA in mid-April due to contamination problems that forced the company to trash the equivalent of […]






